Shares of Enlitic ENL.AX fall 25% to A$0.036, hitting a lifetime low
Stock on track for weakest session since mid December 2024, if current losses hold
U.S.-based healthcare technology firm receives commitments to raise A$10 million ($6.48 million) via a placement
Placement issue price at A$0.04 per Chess Depositary Interest (CDI), a ~16.7% discount of stock's last close
CDIs are instruments that allow non-Australian cos to list their shares on the Australian Stock Exchange
Says funds to be used for co's research and development activities among others
More than 1.6 million shares change hands vs 30-day avg volume of 1.5 million shares
Stock down 33.3% YTD, including current session's moves
($1 = 1.5427 Australian dollars)